Status:
COMPLETED
B Cell Responses in COVID-19
Lead Sponsor:
Fondazione IRCCS Policlinico San Matteo di Pavia
Conditions:
COVID 19
Eligibility:
All Genders
18-90 years
Brief Summary
In this study, we will develop techniques to optimize the in vitro production of human monoclonal antibodies.
Eligibility Criteria
Inclusion
- Age \>18 at time of signing informed consent form
- Signed informed consent form
Exclusion
- Ongoing drug abuse
- Active or history of neoplastic malignancy
- Active autoimmune disease ongoing treatment with immunosuppressive therapy
- Ischemic heart disease
- Evidence of positive HIV, HCV, HBV test
- Diabetes
- Failure to sign informed consent form
Key Trial Info
Start Date :
July 7 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 31 2025
Estimated Enrollment :
4 Patients enrolled
Trial Details
Trial ID
NCT06891170
Start Date
July 7 2021
End Date
March 31 2025
Last Update
April 30 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Fondazione IRCCS Policlinico San Matteo di Pavia
Pavia, Pavia, Italy, 27100